Re: Guidelines for IHC on malignant cases
|From:||John McClure <JMCCLURE@mn.rr.com>|
I can't imagine of a meaningful benchmark that could be applied across the
board. It is so dependent on the H&E appearance that I would strongly
recommend against even attempting to do so.
John S. McClure MD
Pathologist, Unity Hospital
Hospital Pathology Associates
on 6/6/01 3:21 PM, Goodwin, Diana at DGoodwin@CHSNJ.org wrote:
> Does anyone out there in the clinical world know of a standard for
> benchmarking the number of IHCs that are requested on malignant cases? Is
> there a "national average"? The object being to establish a "reasonable"
> average for IHC orders for cost containment purposes.
> Diana Goodwin, HT
> Trenton, NJ
<< Previous Message | Next Message >>